Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adagene
Biotech
ADC Therapeutics calls it quits on Adagene solid tumor collab
ADC Therapeutics is backing out of a 2019 collaboration with Adagene centered on developing ADCs using the latter biotech's antibody-building tech.
Max Bayer
Aug 31, 2023 10:24am
Sanofi looks for a 'safe' bet in $2.5B tie up for Adagene tech
Mar 2, 2022 6:00am
Adagene plans $125M IPO to challenge BMS and Pfizer
Jan 20, 2021 9:00am
China's Adagene bags $69M to advance lead immunotherapies
Jan 8, 2020 7:30am
Adagene bags $50M to take anticancer antibodies into the clinic
Mar 27, 2018 9:25am
